Degenerative, non-atherosclerotic cardiovascular disease in the elderly: a clinico-pathological survey

G Thiene1, M Valente

  • 1Institute of Pathological Anatomy, University of Padova Medical School, Italy.

Aging (Milan, Italy)
|September 1, 1990
PubMed

Insights

Degenerative cardiovascular diseases, not just atherosclerosis, significantly impact elderly health and longevity. Recognizing these non-atherosclerotic disorders is crucial for better health outcomes in older adults.

Area of Science:

  • Gerontology
  • Cardiology
  • Internal Medicine

Background:

  • Cardiovascular disease is the primary cause of mortality in the elderly.
  • Atherosclerosis complications like angina and myocardial infarction are common.
  • Other age-related degenerative cardiac conditions require distinction from normal aging.

Purpose of the Study:

  • To highlight the spectrum of non-atherosclerotic cardiovascular diseases in the elderly.
  • To differentiate these conditions from typical age-related cardiac changes.
  • To emphasize their impact on longevity.

Main Methods:

  • Review of existing literature on cardiovascular diseases in the elderly.
  • Analysis of degenerative cardiac conditions beyond atherosclerosis.
  • Categorization of cardiomyopathies and valvular heart diseases.

Main Results:

  • Aortic stenosis due to calcification and aortic incompetence from media atrophy are prevalent.
  • Mitral valve prolapse can lead to severe mitral incompetence.
  • Various cardiomyopathies, including cardiac amyloidosis, are observed.
  • Atrioventricular block and nonrheumatic atrial fibrillation are common, carrying risks of stroke.
  • Aortic dissecting aneurysm is often linked to hypertension.

Conclusions:

  • Degenerative, non-atherosclerotic cardiovascular disorders play a significant role in elderly mortality.
  • These conditions, including valvular diseases and cardiomyopathies, are critical considerations for longevity.
  • Distinguishing these from atherosclerosis is vital for appropriate management and improved health outcomes.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...